Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
Stopped The study was stopped early due to recruitment challenges
Conditions
- Opioid-Induced Constipation
Interventions
- DRUG: NKTR-118
- DRUG: NKTR-118
- DRUG: Placebo
Sponsor
AstraZeneca